RaQualia Pharma Inc (4579.T)

4579.T on Tokyo Stock Exchange

21 Jun 2018
Change (% chg)

¥24 (+1.74%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


RaQualia Pharma Inc. is a Japan-based company engaged in the research and development of pharmaceutical products. The Company is mainly engaged in the discovery and research, the preclinical trials and part of clinical trials of drugs, as well as the licensing of developed compounds to pharmaceutical companies. The Company is... (more)
No analyst recommendations are available for .


Beta: 1.44
Market Cap(Mil.): ¥21,238.53
Shares Outstanding(Mil.): 19.26
Dividend: --
Yield (%): --


  4579.T Industry Sector
P/E (TTM): -- 30.95 32.74
EPS (TTM): -40.87 -- --
ROI: -19.65 14.84 14.38
ROE: -19.81 16.34 16.08

BRIEF-RaQualia Pharma plans pharmaceutical JV with ZTE Coming Biotech

* Says it plans to set up a JV, which will be engaged in research and development of pharmaceutical, with Shanghai-based firm ZTE Coming Biotech Co., Ltd, in May

29 Jan 2018

BRIEF-RaQualia Pharma to sign license agreements with CJ HealthCare

* Says it plans to sign license agreements with CJ HealthCare regarding RQ-00000004(tegoprazan) and crystal of RQ-00000004(tegoprazan)

28 Dec 2017

BRIEF-RaQualia Pharma signs license agreement with Maruho on selective Na sodium channel blocker

* Says it and Maruho Co Ltd planed to enter into license agreement, regarding selective Na sodium channel blocker, on Dec. 25

25 Dec 2017

Earnings vs. Estimates